facebook

When Does an Eye Freckle Need Biopsy or Treatment Instead of Observation?

Most ocular “freckles” are safer to monitor than to remove. Intervention becomes appropriate when objective thresholds are crossed, typically when a lesion shows suspicious change, has high-risk clinical features, or causes diagnostic uncertainty that cannot be resolved with imaging alone. ³

For conjunctival lesions, biopsy/treatment is more common than for intraocular lesions because tissue can be obtained directly. Features that lower the threshold for excision include:

  • Nodularity or thickening
  • New feeder vessels
  • Rapid enlargement or colour change
  • Atypical sites (fornix, tarsal conjunctiva, caruncle)
  • A flat, patchy adult-onset pattern suggestive of primary acquired melanosis (PAM) ²

For PAM, histology (presence and grade of atypia) and extent guide management. Diffuse disease may require excision with cryotherapy and/or topical chemotherapy under specialist care. ¹ ²

For choroidal tumours, biopsy is less common; decisions are usually imaging-based. When multiple validated risk factors accumulate, early referral and definitive treatment may be recommended rather than prolonged observation. ³

References

  1. Wong JR, Nanji AA, Galor A, Karp CL. Management of conjunctival melanoma and primary acquired melanosis. Clinical Ophthalmology. 2014;8:197-206. doi:10.2147/OPTH.S45987. PMID: 25580155.
  2. Shields JA, Shields CL, Mashayekhi A, Marr BP, Benavides R, Thangappan A, et al. Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Ophthalmology. 2008;115(3):511-519.e2. doi:10.1016/j.ophtha.2007.07.003. PMID: 17884168.
  3. Shields CL, Demirci H, Materin MA, Marr BP, Mashayekhi A, Shields JA. Clinical factors in the identification of small choroidal melanoma. Canadian Journal of Ophthalmology. 2004;39(4):351-357. doi:10.1016/S0008-4182(04)80005-X. PMID: 15327099.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.